Catechol versus bisphosphonate ligand exchange at the surface of iron oxide nanoparticles: towards multi-functionalization
Source abstract
Abstract
We report an investigation of the ligand exchange at the surface of iron oxide nanoparticles in water. For this purpose we compared two strong chelating agents on the iron oxide surface containing catechol and bisphosphonate moieties. Interactions between the coating agents (catechol/bisphosphonate) and the nanoparticle’s surface were studied by FTIR and DFT calculations. Ligand exchange experiments were performed using sonication and the exchange yield was characterized by FTIR and EDX. This methodology allowed introducing bisphosphonates with various functionalities (alkyne or biotin) permitting multi-functionalization.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Iron oxide chemistry and applications · Chemical Synthesis and Characterization · Molecular Junctions and Nanostructures
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Amstad E, Gillich T, Bilecka I, Textor M, Reimhult E (2009) Ultrastable iron oxide nanoparticle colloidal suspensions using dispersants with catechol-derived anchor groups. Nano Lett 9:4042–4048. doi: 10.1021/nl902212q10.1021/nl902212q ↗
2. Amstad E, Gehring AU, Fischer H, Nagaiyanallur VV, HäÌhner G, Textor M, Reimhult E (2011) Influence of electronegative substituents on the binding affinity of catechol-derived anchors to Fe3O4 nanoparticles. J Phys Chem C 115:683–691. doi: 10.1021/jp110930610.1021/jp1109306 ↗
3. Basly B, Felder-Flesch D, Perriat P, Billotey C, Taleb J, Pourroy G, Begin-Colin S (2010) Dendronized iron oxide nanoparticles as contrast agents for MRI. Chem Commun 46:985–987. doi: 10.1039/b920348f10.1039/B920348F ↗
4. Benyettou F, Lalatonne Y, Sainte-Catherine O, Monteil M, Motte L (2009) Superparamagnetic nanovector with anti-cancer properties:γ-Fe2O3@Zoledronate. Int J Pharm 379:324–32710.1016/j.ijpharm.2009.04.010 ↗
5. Benyettou F, Guenin E, Lalatonne Y, Motte L (2011) Microwave assisted nanoparticle surface functionalization. Nanotechnology 22:05510210.1088/0957-4484/22/5/055102 ↗
6. Bloemen M, Brullot W, Luong T, Geukens N, Gils A, Verbiest T (2012) Improved functionalization of oleic acid-coated iron oxide nanoparticles for biomedical applications. J Nanopart Res 14:1–10. doi: 10.1007/s11051-012-1100-510.1007/s11051-012-1100-5 ↗
7. Bolley J, Guenin E, Lievre N, Lecouvey M, Soussan M, Lalatonne Y, Motte L (2013a) Carbodiimide versus click chemistry for nanoparticle surface functionalization: a comparative study for the elaboration of multimodal superparamagnetic nanoparticles targeting αvβ3 integrins. Langmuir 29:14639–14647. doi: 10.1021/la403245h10.1021/la403245h ↗
8. Bolley J, Lalatonne Y, Haddad O, Letourneur D, Soussan M, Perard-Viret J, Motte L (2013b) Optimized multimodal nanoplatforms for targeting αvβ3 integrins. Nanoscale 5:11478–11489. doi: 10.1039/c3nr03763k10.1039/c3nr03763k ↗
9. Collins MW, Koenig CS, Yigit M, Medarova Z (2013) Iron oxide nanoparticles and derivatives for biomedical imaging and application in cancer diagnosis and therapy. In: Micro and nano flow systems for bioanalysis, Springer, New York, pp 1–14. doi: 10.1007/978-1-4614-4376-6_110.1007/978-1-4614-4376-6_1 ↗
10. Colombo M et al (2012) Biological applications of magnetic nanoparticles. Chem Soc Rev 41:4306–4334. doi: 10.1039/c2cs15337h10.1039/c2cs15337h ↗
11. de Montferrand C et al (2012) Size-dependent nonlinear weak-field magnetic behavior of maghemite nanoparticles. Small 8:1945–1956. doi: 10.1002/smll.20110266010.1002/smll.201102660 ↗
12. de Montferrand C et al (2013) Iron oxide nanoparticles with sizes, shapes and compositions resulting in different magnetization signatures as potential labels for multiparametric detection. Acta Biomater 9:6150–6157. doi: 10.1016/j.actbio.2012.11.02510.1016/j.actbio.2012.11.025 ↗
13. Demay-Drouhard P, Nehlig E, Hardouin J, Motte L, Guénin E (2013) Nanoparticles under the light: click functionalization by photochemical thiol-yne reaction, towards double click functionalization chemistry: A. Eur J 19:8388–8392. doi: 10.1002/chem.20130090310.1002/chem.201300903 ↗
14. Dennington R, Keith T, Millam J (2009) GaussView, Version 5. Semichem Inc., Shawnee Mission KS 2009
15. Erathodiyil N, Ying JY (2011) Functionalization of Inorganic Nanoparticles for Bioimaging Applications. Acc Chem Res 44:925–935. doi: 10.1021/ar200032710.1021/ar2000327 ↗
16. Frisch MJ et al. (2009) Gaussian 09. Gaussian, Inc., Wallingford, CT, USA
17. Geinguenaud F, Souissi I, Fagard R, Motte L, Lalatonne Y (2012) Electrostatic assembly of a DNA superparamagnetic nano-tool for simultaneous intracellular delivery and in situ monitoring. Nanomedicine 8:1106–1115. doi: 10.1016/j.nano.2011.12.01010.1016/j.nano.2011.12.010 ↗
18. Georgelin T, Moreau B, Bar N, Villemin D, Cabuil V, Horner O (2008) Functionalization of γ-Fe2O3 nanoparticles through the grafting of an organophosphorous ligand. Sens Actuators B 134:451–454. doi: 10.1016/j.snb.2008.05.02210.1016/j.snb.2008.05.022 ↗
19. Goldmann AS, Schödel C, Walther A, Yuan J, Loos K, Müller AHE (2010) Biomimetic mussel adhesive inspired clickable anchors applied to the functionalization of Fe3O4 nanoparticles. Macromol Rapid Commun 31:1608–1615. doi: 10.1002/marc.20100019310.1002/marc.201000193 ↗
20. Guenin E, Degache E, Liquier J, Lecouvey M (2004) Synthesis of 1-hydroxymethylene-1,1-bis(phosphonic acids) from acid anhydrides: preparation of a new cyclic 1-acyloxymethylene-1,1-bis(phosphonic acid). Eur J Org Chem 2004:2983–298710.1002/ejoc.200400053 ↗
21. Guénin E, Hardouin J, Lalatonne Y, Motte L (2012) Bivalent alkyne-bisphosphonate as clickable and solid anchor to elaborate multifunctional iron oxide nanoparticles with microwave enhancement. J Nanopart Res 14:1–10. doi: 10.1007/s11051-012-0965-710.1007/s11051-012-0965-7 ↗
22. Hu L, de Montferrand C, Lalatonne Y, Motte L, Brioude A (2012) Effect of cobalt doping concentration on the crystalline structure and magnetic properties of monodisperse CoxFe3-xO4 nanoparticles within nonpolar and aqueous solvents. J Phys Chem C 116:4349–4355. doi: 10.1021/jp205088x10.1021/jp205088x ↗
23. Kunugi S, Yamaoka T, Dutta R, Sharma P, Kobayashi H, Pandey A (2012) Functionalized biocompatible nanoparticles for site-specific imaging and therapeutics. In: Polymers in nanomedicine, Springer, Berlin, pp 233–275, doi: 10.1007/12_2011_15510.1007/12_2011_155 ↗
24. Lalatonne Y, Paris C, Serfaty JM, Weinmann P, Lecouvey M, Motte L (2008) Bis-phosphonates-ultra small superparamagnetic iron oxide nanoparticles: a platform towards diagnosis and therapy. Chem Commun 22:2553–255510.1039/b801911h ↗
25. Lenglet L (2009) Multiparametric magnetic immunoassays utilizing non-linear signatures of magnetic labels. J Magn Magn Mater 321:1639–164310.1016/j.jmmm.2009.02.104 ↗
26. Lenglet L, Nikitin P, Péquignot C (2008) Magnetic immunoassays: a new paradigm in POCT IVD technology July/August 43
27. Ling D, Hyeon T (2012) Chemical design of biocompatible iron oxide nanoparticles for medical applications. Small 9:1450–1466. doi: 10.1002/smll.20120211110.1002/smll.201202111 ↗
28. Ling D et al. (2011) Multiple-interaction ligands inspired by mussel adhesive protein: synthesis of highly stable and biocompatible nanoparticles angewandte chemie international edition:n/a-n/a doi: 10.1002/anie.20110152110.1002/anie.201101521 ↗
29. Mahon E, Salvati A, Baldelli Bombelli F, Lynch I, Dawson KA (2012) Designing the nanoparticle-biomolecule interface for ``targeting and therapeutic delivery’’. J Control Release 161:164–174. doi: 10.1016/j.jconrel.2012.04.00910.1016/j.jconrel.2012.04.009 ↗
30. Motte L, Benyettou F, de Beaucorps C, Lecouvey M, Milesovic I, Lalatonne Y (2010) Multimodal superparamagnetic nanoplatform for clinical applications: immunoassays, imaging & therapy. Faraday Discuss 149:211–22510.1039/C005286H ↗
31. Pan Y, Du X, Zhao F, Xu B (2012) Magnetic nanoparticles for the manipulation of proteins and cells. Chem Soc Rev 41:2912–2942. doi: 10.1039/c2cs15315g10.1039/c2cs15315g ↗
32. Papst S, Cheong S, Banholzer MJ, Brimble MA, Williams DE, Tilley RD (2013) One-pot synthesis of water soluble iron nanoparticles using rationally-designed peptides and ligand release. Chem Commun 49:4540–4542. doi: 10.1039/c3cc41751d10.1039/c3cc41751d ↗
33. Perrier T, Saulnier P, Benoît J-P (2010) Methods for the functionalisation of nanoparticles: new insights and perspectives. Chem Eur J 16:11516–11529. doi: 10.1002/chem.20100080810.1002/chem.201000808 ↗
34. Portet D, Denizot B, Rump E, Hindre F, Le Jeune J-J, Jallet P (2001) Comparative biodistribution of thin-coated iron oxide nanoparticles TCION: effect of different bisphosphonate coatings. Drug Dev Res 54:173–181. doi: 10.1002/ddr.1002710.1002/ddr.10027 ↗
35. Pujari SP, Scheres L, Marcelis ATM, Zuilhof H (2014) Covalent surface modification of oxide surfaces. Angew Chem Int Ed 53:6322–6356. doi: 10.1002/anie.20130670910.1002/anie.201306709 ↗
36. Reddy LH, Arias JL, Nicolas J, Couvreur P (2012) Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev 112:5818–5878. doi: 10.1021/cr300068p10.1021/cr300068p ↗
37. Sandiford L et al (2013) Bisphosphonate-anchored PEGylation and radiolabeling of superparamagnetic iron oxide: long-circulating nanoparticles for in vivo multimodal (T1 MRI-SPECT) imaging. ACS Nano 7:500–512. doi: 10.1021/nn304605510.1021/nn3046055 ↗
38. Shultz MD, Reveles JU, Khanna SN, Carpenter EE (2007) Reactive nature of dopamine as a surface functionalization agent in iron oxide nanoparticles. J Am Chem Soc 129:2482–2487. doi: 10.1021/ja065196310.1021/ja0651963 ↗
39. Sperling RA, Parak WJ (2010) Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles. Philos Trans A Math Phys Eng Sci 368:1333–1383. doi: 10.1098/rsta.2009.027310.1098/rsta.2009.0273 ↗
40. Tao J, Perdew JP, Staroverov VN, Scuseria GE (2003) Climbing the density functional ladder: nonempirical meta-generalized gradient approximation designed for molecules and solids. Phys Rev Lett 91:14640110.1103/PhysRevLett.91.146401 ↗
41. Tran P-L, Tran T-D, Vo T, Lee B-J (2012) Promising iron oxide-based magnetic nanoparticles in biomedical engineering. Arch Pharmacal Res 35:2045–2061. doi: 10.1007/s12272-012-1203-710.1007/s12272-012-1203-7 ↗
42. Tudisco C et al (2013) Functionalization of PEGylated Fe3O4 magnetic nanoparticles with tetraphosphonate cavitand for biomedical application. Nanoscale 5:11438–11446. doi: 10.1039/c3nr02188b10.1039/c3nr02188b ↗
43. Turcheniuk K, Tarasevych AV, Kukhar VP, Boukherroub R, Szunerits S (2013) Recent advances in surface chemistry strategies for the fabrication of functional iron oxide based magnetic nanoparticles Nanoscale 5:10729–10752. doi: 10.1039/c3nr04131j
44. Wang L et al (2006) A biocompatible method of decorporation: bisphosphonate-modified magnetite nanoparticles to remove uranyl ions from blood. J Am Chem Soc 128:13358–13359. doi: 10.1021/ja065135510.1021/ja0651355 ↗
45. Wu A, Ou P, Zeng L (2010) Biomedical applications of magnetic nanoparticles. Nano 05:245–270. doi: 10.1142/S179329201000216510.1142/S1793292010002165 ↗
46. Yigit MV, Moore A, Medarova Z (2012) Magnetic nanoparticles for cancer diagnosis and therapy. Pharm Res 29:1180–1188. doi: 10.1007/s11095-012-0679-710.1007/s11095-012-0679-7 ↗
47. Yuen AKL, Hutton GA, Masters AF, Maschmeyer T (2012) The interplay of catechol ligands with nanoparticulate iron oxides. Dalton Trans 41:2545–2559. doi: 10.1039/c2dt11864e10.1039/c2dt11864e ↗